Results 151 to 160 of about 13,385 (164)

Resistance to echinocandin-class antifungal drugs

Drug Resistance Updates, 2007
David S Perlin
exaly  

Activity of CD101, a long-acting echinocandin, against clinical isolates of

Diagnostic Microbiology and Infectious Disease, 2018
Shawn R Lockhart, Elizabeth L Berkow
exaly  

Total synthesis and structure–activity relationships of new echinocandin-like antifungal cyclolipohexapeptides

European Journal of Medicinal Chemistry, 2012
Zhenyuan Miao, Chunquan Sheng, Wannian Zhang   +2 more
exaly  

Preparative separation of echinocandin B from broth using macroporous resin adsorption chromatography

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 2015
Yu-Guo Zheng, Shu-Ping Zou, Kun Niu
exaly  

Genetic Basis of Azole and Echinocandin Resistance in Clinical Candida glabrata in Japan.

Antimicrobial Agents and Chemotherapy, 2020
Hazim O Khalifa, Teppei Arai, Akira Watanabe   +2 more
exaly  

Molecular Confirmation of the Relationship between Candida guilliermondii Fks1p Naturally Occurring Amino Acid Substitutions and Its Intrinsic Reduced Echinocandin Susceptibility.

Antimicrobial Agents and Chemotherapy, 2017
Guillermo Garcia-Effron, Florencia Leonardelli, Daiana Macedo   +2 more
exaly  

Novel FKS1 and FKS2 modifications in a high-level echinocandin resistant clinical isolate of Candida glabrata

Emerging Microbes and Infections, 2019
Kelley R Healey, He Wang, David S Perlin
exaly  

Safety and Pharmacokinetics of CD101 IV, a Novel Echinocandin, in Healthy Adults.

Antimicrobial Agents and Chemotherapy, 2017
Voon Ong, Taylor Sandison
exaly  

Anidulafungin: a new echinocandin for candidal infections

Expert Review of Anti-Infective Therapy, 2007
Annette C. Reboli
exaly  

Anidulafungin: an echinocandin antifungal

Expert Opinion on Investigational Drugs, 2004
exaly